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Innate immunityAutophagy is a conserved eukaryotic mechanism that mediates the removal of long-lived cytoplasmic
macromolecules and damaged organelles via a lysosomal degradative pathway. Recently, a multitude of
studies have reported that viral infections may have complex interconnections with the autophagic process.
These observations strongly imply that autophagy has virus-speciﬁc roles relating to viral replication, host
innate and adaptive immune responses, virus-induced cell death programs, and viral pathogenesis.
Autophagy can supply internal membrane structures necessary for viral replication or may prolong cell
survival during viral infections and postpone cell death. It can inﬂuence the survival of both infected and
bystander cells. This process has also been linked to the recognition of viral signature molecules during
innate immunity and has been suggested to help rid the cell of infection. This review discusses interactions
between different viruses and the autophagy pathway, and surveys the current state of knowledge and
emerging themes within this ﬁeld.dson).
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Macroautophagy (hereafter referred to as autophagy) is a tightly
regulated and evolutionarily conserved mechanism for the seques-
tration, lysosomal degradation, and recycling of discrete intracellular
portions of eukaryotic cells, facilitating the removal of materials not
typically degraded by the ubiquitin–proteosomal pathway. Regulators
of this process include hormones and growth factors that suppress
autophagy during cellular growth, as well as intracellular levels of
nutrients, oxygen, and energy, allowing the pathway to act as a
defense mechanism against inducers of cellular stress (Pattingre et al.,
2008; Wullschleger et al., 2006; Yang et al., 2005). Perturbations in
autophagy have been correlated with numerous pathological condi-
tions, including oncogenesis and cancer progression, neurodegener-
ative disorders, liver disease, myopathy, and cardiac disease,
highlighting the importance of this pathway in human health and
cellular homeostasis (Levine and Kroemer, 2008; Meijer and Codogno,
2006; Mizushima et al., 2008). Autophagy has been shown to play an
important role in the pathogenesis of several viral infections and is
suggested to act as both an inducer and effector of innate and adaptive
immune responses against intracellular pathogens, including viruses.
Currently, evidence suggests that viruses have evolved a diverse array
of countermeasures to contend with this pathway; some inhibit
autophagy and are negatively affected when this interference is
abrogated, while others appear to subvert it to their own ends andrespond positively when it is induced. However, still other viruses are
seemingly unaffected by autophagy, and do not appear to regulate the
pathway through any apparent mechanism(s). This review seeks to
provide both a synopsis of currently known and suspected viral
interactions with the autophagy pathway, and to stimulate a critical
discussion concerning the central trends that have been suggested
within this ﬁeld of research.
Overview of the mechanisms and regulation of autophagy
For the sake of brevity, only an overview of the mechanisms and
regulation of the autophagy mechanism will be provided. The reader
is referred to more detailed reviews concerning speciﬁc aspects of
autophagy, such as the formation and maturation of the autophago-
some (Longatti and Tooze, 2009; Mizushima, 2007; Noda et al., 2009;
Reggiori and Klionsky, 2005; Xie and Klionsky, 2007; Yang et al., 2005;
Yoshimori and Noda, 2008), regulatory mechanisms of this pathway
(Meijer and Codogno, 2004; Pattingre et al., 2008; Wullschleger et al.,
2006; Yang et al., 2005), roles in innate antigen recognition and MHC
antigen presentation (Delgado et al., 2009; Delgado and Deretic, 2009;
Levine and Deretic, 2007; Münz, 2006; Orvedahl and Levine, 2009;
Schmid and Münz, 2005; Virgin and Levine, 2009), and the
relationship between autophagy and regulated cell death (Codogno
and Meijer, 2005; Ferraro and Cecconi, 2007; Kroemer and Levine,
2008; Maiuri et al., 2007; Scarlatti et al., 2009). The core process of
autophagy is the de novo synthesis of a double-membrane-bound
vesicle capable of fusing with an endosome or lysosome, which
ultimately leads to the catabolic degradation of the encapsulated
cargo (Fig. 1). Inmammals, this process beginswith the expansion of a
Fig. 1. Overview of the autophagy process. In response to cellular stimuli such as starvation and immune signals, the class I PI(3)K (phosphoinositide 3-kinases)-induced Atg1
complex and a class III PI(3)K complex involving Beclin-1 activate downstream ATG proteins in a series of steps that guide the induction, elongation, maturation, and degradation of
the autophagosome. Two ubiquitin-like conjugation systems involving Atg12 (a) and LC3 (b) direct the vesicle elongation of the isolation membrane, which forms a crescent shape
to sequester the cytoplasmic cargo. Upon completion, the autophagosome then undergoes the maturation step through a series of remodeling processes including fusion with
endosomes/lysosomes. Fusion with lysosome helps the autophagosome mature into an autolysosome in which the autophagic vacuole along with its content is degraded.
2 Minireviewsmall, ﬂat membrane sac of uncertain origin (termed the isolation
membrane or phagophore). As autophagy-related (Atg) proteins are
recruited to its surface, this membrane sac elongates and curves until
the ends merge to form a double-membrane-bound vesicle (autop-
hagosome). Atg proteins are then recovered or disassociate from the
autophagosome, and the completed structure fuses with an endosome
(amphisome) or lysosome (autolysosome). A brief overview of
mammalian genes of particular signiﬁcance in the regulation and
execution of autophagy is provided in Table 1.
Central in the regulation of autophagy are two key proteins: mTOR
and Beclin-1 (Pattingre et al., 2008; Sinha and Levine, 2008;Wullschleger
et al., 2006). mTOR, a conserved serine/threonine kinase, is a compo-
nentofprotein complexes that integrate cellular signals relating togrowth
factors, nutrient and energy status, and cellular stress (Wullschleger et al.,
2006). Important activators of mTOR include the class I PI3K-Akt/PKB
signaling pathway and high concentrations of speciﬁc amino acids; high
AMP/ATP ratios and hypoxia inactivate this pathway (Arsham and
Neufeld, 2006; Beugnet et al., 2003; Pattingre et al., 2008;Wullschleger et
al., 2006). Activated mTOR suppresses autophagy, enhancing the
accumulation of cellular bulk by limiting lysosomal digestion. Down-
stream of mTOR, Beclin-1 is at the heart of a regulatory complex for the
class III PI3K hVps34, whose activity is essential during autophagosome
formation. Activators, such as UV radiation resistance associated gene
(UVRAG), Bax-interacting factor-1 (Bif-1), and activating molecule in
Beclin-1-regulated autophagy-1 (Ambra-1) associate with the Beclin-1
complex and enhance PtdIns(3)P production, while the Bcl-2 family anti-
apoptotic proteins such as Bcl-2 and Bcl-xL bind to Beclin-1 and act in
an inhibitory fashion (Pattingre et al., 2008; Sinha and Levine, 2008).
TheBcl-2-related inhibitionof autophagy is abrogatedby stress-activated
c-Jun N-terminal protein kinase 1 (JNK1) phosphorylation and compe-
tition from other BH3 binding domain-containing proteins, providing
one of several directmechanistic links between autophagy and apoptosis
(Sinha and Levine, 2008; Wei et al., 2008a,b).Numerous other cellular factors have been shown or are hypoth-
esized to regulate autophagy, many of which have importance in
viral infections. The eukaryotic initiation factor-2 alpha (eIF2α) and
the starvation-responsive general control nonderepressible-2 (GCN2)
eIF2α kinase are both indispensable for starvation-induced autop-
hagy, suggesting that other eIF2α kinases with important roles in
antiviral defense, such as double-stranded RNA (dsRNA)-dependent
protein kinase (PKR) and PKR-like ER kinase (PERK), may also up-
regulate this pathway in response to cellular stressors (Kouroku et al.,
2007; Tallóczy et al., 2002, 2006). Immune signaling molecules can
modulate autophagy; type II interferon-γ (IFN-γ) and tumor-necrosis
factor-α (TNF-α) are stimulatory, while the TH2-type cytokines
interleukin-4 (IL-4) and IL-13 are suppressive (Deretic, 2005; Levine
and Deretic, 2007). Certain pathogen-associated molecular patterns
(PAMPs) trigger autophagy through their cognate pattern recognition
receptors (PRRs), including Toll-like receptor 3 (TLR3), TLR4, and
TLR7, although the molecular mechanism(s), physiological function
(s), and range of PRRs that induce this pathway are all areas of
continuing research (Delgado et al., 2009; Delgado and Deretic, 2009;
Orvedahl and Levine, 2009). The p53 protein possesses a dual role
in the regulation of autophagy dependent upon its localization;
cytoplasmic p53 represses autophagy and must be degraded for
autophagy to proceed, whereas nuclear p53 appears to induce it
(Maiuri et al., 2009; Tasdemir et al., 2008). Many additional cellular
factors, including extracellular signal-regulated kinase (Erk1/2)
activation (Pattingre et al., 2003; Shinojima et al., 2007; Wang et al.,
2009), intracellular release of calcium (Gordon et al., 1993; Høyer-
Hansen and Jäättelä, 2007), increases in reactive oxygen species (ROS)
(Djavaheri-Mergny et al., 2007; Djavaheri-Mergny et al., 2006;
Scherz-Shouval and Elazar, 2007; Scherz-Shouval et al., 2007), and
endoplasmic reticulum (ER) stress (Ding et al., 2007; Kouroku et al.,
2007; Ogata et al., 2006; Yorimitsu et al., 2006) have also been shown
to trigger the pathway to autophagy.
Table 1
Signiﬁcant genes in the mammalian autophagy pathway.
Gene Important interactions Protein function/characteristics
Formation of autophagosomes
ULK1 (ATG1) Atg13, FIP200 (Atg17) Ser/Thr kinase activity important for function; target(s) unknown. Downstream of mTOR signaling.
Potentially involved in Atg9 cycling.
Beclin-1 (ATG6) hVps34, Bcl-2/Bcl-xL, UVRAG Structural regulator of class III PI3 kinase hVps34. Contains BH3-like domain that is down-regulatory
when occupied.
hVPS34 Beclin-1, mTOR Class III PI3 kinase; resulting PtdIns(3)Ps recruit Atg16L multimer/Atg18 to phagophore. Conﬂictingly
activates mTor in response to amino acids.
ATG9 Atg2, Atg18 Transmembrane protein. Transits between phagophores and trans-Golgi/late endosomes. Possible role(s)
in protein recycling and/or membrane transit.
ATG12 Atg5, Atg16L Covalently bound to Atg5 via mechanism similar to ubquitination.
ATG7 LC3, Atg12 Functionally similar to E1 ubiquitin activating enzyme (E1-like). Activates C-terminal glycine
of both Atg12 and LC3.
ATG10 Atg12, Atg5 Functionally similar to E2 ubiquitin conjugating enzyme (E2-like). Accepts activated Atg12 and conjugates
to internal lysine of Atg5.
ATG5 Atg12, Atg16L Covalently bound to Atg12; conjugation allows Atg5 to associate with Atg16L.
ATG16L Atg5–Atg12 Associates with Atg12–Atg5 and dimerizes. Present on outer surface of expanding phagophore;
aids membrane curvature and LC3 recruitment (E3-like). Recycled.
ATG4 LC3 Cysteine protease; exposes C-terminal glycine on LC3 prior to lipidation. Subsequently recycles LC3 from
outer membrane of autophagosome.
ATG3 LC3, Atg7 Functionally similar to E2 ubiquitin conjugating enzyme (E2-like). Conjugates LC3 with
phosphatidylethanolamine (PE) phospholipid.
MAP1LC3 (ATG8) Atg4 Experimental marker of induction. Cytosolic form (LC3-I) conjugated to PE, becoming
membrane-associated (LC3-II). Possible role(s) in membrane expansion, autophagosome
transit, and lysosomal fusion. Partially recycled by Atg4.
Regulation of autophagy
PI3K (class I) Produces PtdIns(3)p that activates the Akt/PKB-mTor pathway.
PTEN Phosphatase that counteracts PI3K by dephosphorylating PtdIns(3)p.
AKT/PKB PDK1, Tsc 2 Ser/Thr kinase. Activated by PDK1 in the presence of PtdIns(3)p. Inactivates Tsc 2.
REDD1/REDD2 Transcriptionally up-regulated in response to hypoxia. Inactivates mTor pathway.
AMPK LKB1, Tsc2 Activates Tsc2, leading to the induction of autophagy when the AMP/ATP ratio is high.
TSC2 Tsc1, Rheb, Akt/PKB, AMPK GTPase-activating protein (GAP) with Tsc1; inactivates Rheb. Akt/PKB interferes with function, as does
Erk1/2. AMPK enhances activity.
Rheb Tsc1/Tsc2, mTor Small GTPase. Activates mTor via binding kinase domain in GTP-dependent fashion. Tsc1/Tsc2 GAP activity
converts to inactive, GDP-bound form.
mTOR Rheb, raptor, mLST8 Key regulator of cellular growth. Autophagy induced when mTor inactivated. Ser/Thr kinase. Forms two
protein complexes; mTORC1 associated with autophagy.
Anti-apoptotic Bcl-2 family Beclin-1 Inhibit autophagy via binding with BH3 motif on Beclin-1. JNK1-mediated phosphorylation disrupts
interaction and associated inhibition.
BH3-only Bcl-2 family Anti-apoptotic Bcl-2 family Competitively bind with anti-apoptotic Bcl-2 family members, interfering with their association with
Beclin-1. Stimulate autophagy.
JNK1 Anti-apoptotic Bcl-2 family Phosphorylates anti-apoptotic Bcl-2 family members, inhibiting interaction with Beclin-1. Activity induces
autophagy.
UVRAG Bif-1, Beclin-1 Interacts with Beclin-1's coiled-coil domain, strengthening Beclin-1/hVps34 interactions; promotes
autophagy. Possible additional role in lysosome fusion.
p53 Controversial/contradictory role(s) in autophagy. P53-dependent autophagy observed experimentally.
However, cytosolic p53 is inhibitory (mechanism unknown).
DRAM Transmembrane lysosomal protein transcriptionally induced by p53. Stimulates autophagy. Necessary
for both p53-dependent autophagy and apoptosis.
3MinireviewWhile numerous experimental approaches including electron
microscopy, LC3 lipidation (aggregation and modiﬁcation), and
protein degradation studies, amongst others, can be employed to
identify or quantify autophagy in higher eukaryotes, a few warnings
should be considered regarding the speciﬁc challenges these methods
present. First, as autophagy is a process with numerous components,
steps, and phases, it is important to clarify whether a given assay
measures a step within this pathway (such as LC3 lipidation) or its
overall physiological consequence (the aim of protein degradation
studies). Since several viruses have been shown to modulate
autophagy at multiple stages with varying effects, it is often necessary
to combine assays examining both induction and maturation in order
to make accurate observations. Second, while autophagy is a
responsive cellular process, capable of ﬂuctuation, most assays
capture this dynamic process at a single static moment in time. This
can pose challenges, as cellular populations are frequently asynchro-
nous and the effects of a viral infection may vary during the course of
the cell cycle. Finally, as different cell types have been shown to
display different autophagy responses, it can be difﬁcult to make
direct comparisons between different virus-cell systems. Particularcaution should be used when studying viruses, like HIV-1, which
infect more than one cell type. For further information regarding the
limitations of current autophagy assays, readers are advised to consult
excellent reviews on this subject (Klionsky et al., 2008; Mizushima,
2004).Viral interactions with the autophagy pathway
Many viruses have been shown to evade, subvert, or exploit
autophagy, seemingly to insure their own replication or survival
advantage, while others are apparently unaffected by this intrinsic
pathway and fail to modulate it by any detectable way. The following
discussion concerning viral infection, autophagy, and host immunity
has been structured on four emergent themes that have been iden-
tiﬁed in the research published to date; autophagy as 1) a mechanism
for membrane remodeling, 2) a digestive defensive response, 3) a
means of cellular surveillance, and 4) a cellular fate-determining
process. A comprehensive summary of viruses for which studies have
been undertaken is provided in Table 2.
4 MinireviewAutophagy is a mechanism for remodeling internal membranes associated
with viral replication
For many viruses, the production of progeny virion is intimately
associated with host cell membranes or cytoskeletal elements. As
such, many viruses are known to subvert host endosomal and
secretory pathways in order to induce host membrane alterations
that can then support viral replication and assembly (Miller and
Krijnse-Locker, 2008). A number of viruses have been shown to
replicate in, or in close association with, multi-membraned vesicles
that possessmany of the characteristics of autophagosomes. Given the
nature and location of these vacuoles, there is strong evidence that
autophagosomes may serve as a site of viral replication during some
infections and that the autophagy pathway might therefore be
exploited by viruses to enhance virion production. Supporting this
assertion, the membranes associated with viral replication are often
derived from the ER, which has also been suggested as a source of the
autophagic double-membrane (Mijaljica et al., 2006). Indeed, the
similarities between autophagic vacuoles and some virally induced
membrane alterations has lead to increased suspicion, and in someTable 2
Brief summary of known interactions between autophagy and viral infections.
Virus Known interaction(s) with autophagy
Adenovirus Contradictory results; autophagy may enhance
adenovirus-induced cell death; differences poss
Coronavirus Contradictory evidence. May induce or subvert
Autophagy may enhance viral replication.
Coxsackievirus Autophagosome formation enhances CVB3/CVB
affects virally induced apoptosis.
Cytomegalovirus Inhibits autophagy through unidentiﬁed mecha
Dengue virus Induces autophagy. Disruption reduces corresp
co-localization observed with serotype-speciﬁc
Drosophila C virus Induces formation of COPI-dependent vesicles.
mechanism unknown.
Enterovirus 71 Induces/co-localizes with autophagic membran
Mechanism unclear.
Epstein–Barr virus Autophagy may aid EBV MHC-II antigen presen
exists. Possibly part of proliferation regulation.
Hepatitis B virus Encodes transcriptional transactivator HBx, resu
of Beclin-1. Sensitizes cells to autophagy signal
Hepatitis C virus Induces autophagy; inhibits maturation. Knock
or ER stress response limits replication. Autoph
presentation/TLR detection in some cell types.
Herpes simplex virus type I Viral encoded ICP34.5 antagonizes pathway thr
induction, as well as Beclin-1 binding. Autopha
in vitro, but essential for neurovirulence in vivo
Human immunodeﬁciency virus Autophagy-related mechanism part of envelope
death and HIV dementia. Pathway dysregulated
some components identiﬁed as necessary host
Inﬂuenza virus Induces autophagosome formation; inhibits ma
viral yield. May enhance MHC-II antigen presen
Kaposi's sarcoma-associated
herpesvirus
Encodes viral homolog of Bcl-2 that inhibits au
interactions with Beclin-1's BH3 domain. Viral
inhibition of Atg3.
Parvovirus Induces formation of autophagosome-like vesic
urvival during viral replication process.
Poliovirus Induces formation of double-membrane, LC3-p
and release. Viral 2BC protein triggers LC3 lipid
Rhinovirus Does not induce or modulate autophagy. Replic
inhibition of pathway.
Sendai virus In pDCs, autophagy enhances delivery of viral n
TLR7 recognition.
Sindbis virus In vivo up-regulation of autophagy via Beclin-1
encephalitis in mice.
Tobacco mosaic virus Autophagy necessary to restrict virally induced
responses to the site of infection.
Vaccinia virus Induces vesicle formation, but mechanism inde
Varicella-zoster virus Induces autophagy. Role in infection unclear.
Vesicular stomatitis virus Autophagy enhances endocytic detection in pD
detection/antiviral responses in other cell typecases proof, of a connection between positive-stranded RNA viral
replication and the autophagy mechanism.
A link between poliovirus (PV)-induced double-membrane vesi-
cles and autophagy has long been suggested, and is often cited as the
classic example of viral exploitation of the autophagy pathway.
Ultrastructural and biochemical analyses have revealed that PV
induces massive rearrangements in intracellular membranes, result-
ing in clusters of double-membrane-bound vesicles capable of
supporting viral replication complexes (Bienz et al., 1987; Rust
et al., 2001; Schlegel et al., 1996; Suhy et al., 2000). These PV-induced
vesicles display the classic autophagosomal marker LC3, which has
been hypothesized to be directly recruited by viral proteins (Jackson
et al., 2005; Taylor and Kirkegaard, 2007). Subsequent studies have
further shown that additional secretory vesicle trafﬁcking molecules
are also recruited during the formation of these membranous
replicative vesicles (Belov et al., 2007), and that the association of
these vesicles with the microtubule network aids in the non-lytic
release of PV virion particles (Taylor et al., 2009). Hence, it has been
postulated that PV factors initiate elements of both the interrelated
secretory trafﬁcking and autophagy pathways to ultimately create aKey references
or detract from engineered
ibly cell-type/virus-speciﬁc.
Ito et al. (2006); Baird et al. (2008)
autophagy membrane remodeling. Prentice et al. (2004a);
Zhao et al. (2007)
4 replication in vitro. Autophagy Wong et al. (2008); Yoon et al.
(2008)
nism. Chaumorcel et al. (2008)
onding viral titers. Membrane
differences.
Lee et al. (2008); Panyasrivanit et al.
(2009); Khakpoor et al. (2009)
Interactions with autophagy Cherry et al. (2006)
es. Induction increases viral titer. Huang et al. (2009)
tation, but contradictory evidence Paludan et al. (2005); Lee and
Sugden (2008)
lting in increased expression
s.
Tang et al. (2009)
down of autophagy genes
agy may aid HCV antigen
Sir et al. (2008); Dreux et al. (2009)
ough inhibition of PKR/eIF2a
gy effects of minimal importance
.
Tallóczy et al. (2006); Alexander et al.
(2007); Orvedahl et al. (2007);
English et al. (2009)
protein-induced bystander T cell
in some infected cell types, but
co-factors.
Espert et al. (2006); Alirezaei et al.
(2008); Zhou and Spector (2008);
Espert et al. (2009); Kyei et al. (2009)
turation. Interference decreases
tation.
Gannagé et al. (2009);
Zhou et al. (2009)
tophagy through binding
FLIP suppresses autophagy through
Pattingre et al. (2005); Ku et al.
(2008); Lee et al. (2009)
les, possibly to extend host cell s Nakashima et al. (2006)
ositive vesicles. Aids viral replication
ation.
Jackson et al. (2005); Taylor and
Kirkegaard (2007)
ation unaffected by induction or Jackson et al. (2005); Brabec-Zaruba
et al. (2007)
ucleic acids to endosomes for Lee et al. (2007)
over-expression reduces fatal Liang et al. (1998)
programmed cell death Liu et al. (2005)
pendent of autophagy. Zhang et al. (2006)
Takahashi et al. (2009)
Cs, but may diminish cytosolic
s.
Jounai et al. (2007); Lee et al.
(2007); Shelly et al. (2009)
5Minireviewmembranous structure capable of supporting both viral replication
and virion egress. Besides PV, several other picornaviruses also appear
to subvert the autophagy machinery to promote their replication.
The group B Coxsackieviruses, CVB3 and CVB4, induce autophago-
some formation, and biochemical inhibition of this pathway nega-
tively impacts virion production (Wong et al., 2008; Yoon et al.,
2008). Similarly, the enteropathogen EV71 has been shown to trigger
autophagy in vitro, and that this induction can signiﬁcantly increase
viral yield (Huang et al., 2009). Apart from the Picornaviridae family,
two Dengue virus (DENV) serotypes (DENV-2 and DENV-3) have
also been shown to interact with the autophagy machinery to promote
their replication (Khakpoor et al., 2009; Lee et al., 2008; Panyasrivanit
et al., 2009). Interestingly, the stage of the autophagic process with
which DENV is associated varies depending upon the viral serotype
involved; DENV-2 translation/replication complex has been shown to
speciﬁcally locatewith pre-lysosomal fusion amphisomes, while DENV-
3 requires further vesicle maturation and post-lysosomal fusion
vacuoles (autolysosomes) to efﬁciently produce virions (Khakpoor
et al., 2009; Panyasrivanit et al., 2009). The autophagy pathway also
appears to be critical in the replication of another Flaviviridaemember,
namely the hepatitis C virus (HCV), which has also been shown to
induce autophagosome formation (Ait-Goughoulte et al., 2008; Dreux
et al., 2009; Sir et al., 2008; Tanida et al., 2009). In the case of HCV,
autophagy is thought to be responsible for providing membranous
support structures during the initial translation and de novo replication
of HCV RNA following infection, but subsequently contributes little to
virus maturation once an infection is stably established in the host cell
(Dreux et al., 2009; Tanida et al., 2009). Finally, basal levels of autophagy
have recently been shown to enhance macrophage-tropic human
immunodeﬁciency virus (HIV) viral protein processing and virion
production in vitro, suggesting a role for autophagy in HIV biosynthesis
in this cell type (Kyei et al., 2009).
While these results are strongly suggestive that viruses can
subvert or induce autophagy in order to create advantageous mem-
brane alterations, other research has demonstrated that this effect
is not universal. Not all viral infections that induce membrane
alterations, including some which are closely related to the examples
provided above, modulate or are affected by the autophagy pathway.
The replication of human rhinovirus 2, a picornavirus that shares
many similarities with PV, is not affected by drugs that either inhibit
or induce autophagy, and does not elicit the formation of LC3-positive
vesicles (Brabec-Zaruba et al., 2007). Contradictory observations have
been made for the Coronaviridae members, murine hepatitis virus
(MHV) and severe acute respiratory syndrome-coronavirus (SARS-
CoV); some studies have suggested that endogenous LC3 co-localizes
with SARS-CoV and MHV vacuole-associated replicase proteins
(Prentice et al., 2004a,b), yet other studies have had difﬁculty corrob-
orating these results (de Haan and Reggiori, 2008; Snijder et al., 2006;
Stertz et al., 2007). In line with these observations, MHV viral
replication and release have been shown to be comparable in cells
with both normal and defective autophagy mechanisms (Zhao et al.,
2007). Likewise, the viral production kinetics of vaccinia virus, which
has been shown to utilize double-membrane vesicles for its
replication, was similar in wild-type, Atg5−/−, and Beclin-1-deﬁcient
cells (Zhang et al., 2006). Thus, subversion of autophagy as a mecha-
nism for inducing membrane alterations may be either cell-type- or
virus-dependent. These results suggest that considerable care should
be exercised prior to concluding that autophagy is the mechanism
responsible for membrane alterations observed under microscopy to
ensure that they are biochemically and mechanistically connected to
this pathway. While the evidence to date strongly indicates a positive
role for autophagy in the replication of some viruses, the observed
variation, particularly amongst closely related viruses, suggests that
other mechanisms may exist for inducing similar alterations in
host cells. One should approach these studies carefully with the
correct diagnostic tools for autophagy.Autophagy can be a mechanism for defense: the digestion or elimination
of unwanted viral intruders
As the previous section has indicated, viruses may induce
autophagy for their own replicative advantage; yet, the same process
may also conﬁne viral replication complexes within vesicles as an
innate defense against infection (Wileman, 2006). Furthermore,
autophagy has been documented to function as a host cell defense
against some intracellular pathogens. This process, which has been
termed xenophagy (‘to eat what is foreign’), results in the autophagic-
lysosomal destruction of invading pathogens. Several bacterial patho-
gens including Mycobacterium tuberculosis (Gutierrez et al., 2004),
group A Streptococcus (Nakagawa et al., 2004), Shigella ﬂexneri (Ogawa
et al., 2005), Legionella pneumophila (Amer and Swanson, 2005), and
Yersinia pestis (Pujol et al., 2009) have been shown to either actively
inhibit or be degraded through xenophagy. Subsequently, this process
has been demonstrated to be particularly important in restricting
bacterial escape and survival. Just as xenophagy restricts certain
bacterial pathogens, autophagy may capture replicating viruses or
newly assembled virions within their host cells, and eliminate them
through sequestration and lysosomal degradation (Kirkegaard et al.,
2004; Levine, 2005; Wileman, 2007).
The initial hypothesis that autophagy might function as an
antiviral defense mechanism was suggested when the autophagy
effector and regulatory protein Beclin-1 was shown to be an antiviral
effector in mice infected with the neurotropic Sindbis virus (SINV)
(Liang et al., 1998). Over-expression of Beclin-1 protected mice from
fatal SINV encephalitis, reducing neuronal apoptosis and decreasing
SINV viral replication (Liang et al., 1998). The antiviral and anti-
apoptotic effects attributed to Beclin-1 in SINV infection in vivo
suggested that autophagy may function as a defense against other
viral infections. Since these initial observations were ﬁrst published,
further evidence has shown that autophagymay function as a defense
against viral infections.
Similar effects to those observed with SINV infection have been
demonstrated in HSV-1 encephalitis (Orvedahl et al., 2007). In murine
ﬁbroblasts and neurons, mutant HSV-1 deﬁcient in ICP34.5, a
viral Beclin-1-interacting protein, but not wild-type virus, induced
autophagy upon infection in a PKR-dependent manner (Alexander
et al., 2007; Orvedahl et al., 2007; Tallóczy et al., 2002, 2006). This
viral induction of autophagy resulted in the observed localization
and xenophagic degradation of virions within autophagosomes
(Alexander and Leib, 2008; Alexander et al., 2007; Tallóczy et al.,
2006). However, the exact signiﬁcance of increased mutant virions
within double-membrane vesicles and xenophagy is questionable,
since suppression of autophagy through the use of Atg5−/− mouse
embryonic ﬁbroblasts (MEFs) did not signiﬁcantly alter the replica-
tion efﬁciency of either wild-type or ICP34.5 mutant HSV-1 in vitro
(Alexander et al., 2007; Jounai et al., 2007). In the case of HSV-1, it
is thought that while ICP34.5 expression can inhibit autophagy in
infected cells, the prevention of PKR-mediated translational arrest,
rather than regulation of autophagy, may be the pivotal determi-
nant of HSV-1 replicative efﬁciency in cell culture (Alexander et al.,
2007). In contrast to these in vitro observations, the suppression
of autophagy in vivo by ICP34.5 appears to be critical in HSV-1
pathogenesis, since Beclin-1-binding-deﬁcient ICP34.5 mutant
viruses are neuroattenuated with regards to lethal encephalitis
in mice (Orvedahl et al., 2007). Interestingly, this HSV-1 mutant's
virulence can be reconstituted if the infection is conducted in mice
deﬁcient for the antiviral effector PKR (Orvedahl et al., 2007).
The observed discrepancies between in vitro and in vivo results may
be due to cell-type dependent differences, and/or the effects of
other HSV-1 proteins on the autophagy pathway (Alexander and Leib,
2008).
The observation that a HSV-1 viral protein that abrogates
autophagy is necessary in vivo to observe certain pathogenic
6 Minirevieweffects, highlights the potential antiviral function of this pathway.
This may be particularly true in the case of neurotropic viruses,
since modulation of autophagy has been suggested to inﬂuence the
development of certain neurological diseases, (Itzhaki et al., 2008;
Orvedahl and Levine, 2008). Along these lines, it has been noted
that feline, simian, and human immunodeﬁciency viral infections
in vivo can indirectly induce deﬁcits in neuronal autophagy, and
that this effect may contribute to the neuro-inﬂammatory pathol-
ogy observed in these diseases (Alirezaei et al., 2008; Zhu et al.,
2009). Thus, the dysregulation of autophagy by certain neurotropic
viruses may not only interfere with their lysosomal clearance, but
may also have a signiﬁcant impact in terms of their pathogenic
effect.
One remaining question though is whether xenophagy truly
functions as an antiviral effector mechanism, since only HSV-1 viral
particles have been observed microscopically within the conﬁnes of
autophagosomes. Furthermore, this effect may be virus-speciﬁc rather
than a general defensive mechanism of viral clearance. While it is
tempting to speculate that xenophagy, as demonstrated within the
ﬁeld of bacteriology, exists as a general host defense mechanism
for the clearance of all intracellular pathogens, including viruses,
the limited amount of direct evidence available at this time suggests
that caution is warranted. In particular, care should be exercised
in differentiating between the incidental inclusion of virion or viral
components within autophagosomes due to either their uptake
by background or stress-induced activation of this pathway, and
enhanced, autophagosome-driven clearance of these materials.
The HSV-1 ICP34.5 protein is known to antagonize PKR by
dephosphorylating eIF2α (He et al., 1997), and, as discussed above,
also blocks the induction of autophagy in a PKR-dependent fashion
(Orvedahl et al., 2007; Tallóczy et al., 2002, 2006). As many viruses
employ numerous countermeasures for disrupting the IFN and PKR
antiviral systems, these viral disturbances may also have signiﬁcance
in modulating downstream autophagic processes. Indeed, unless a
virus can inhibit autophagy it is subject to the effects of immune
surveillance which harnesses the autophagy machinery (discussed in
Autophagy may function in security surveillance: a watchdog for
foreign molecules section).
Autophagy may function in security surveillance: a watchdog for foreign
molecules
In addition to xenophagy, autophagy may function as an antiviral
pathway in a less direct fashion, sampling and delivering cytoplasmic
material to cellular compartments (endosomes and lysosomes). This
process may play a signiﬁcant role in the activation of innate and
adaptive immune responses to foreign pathogens. Research has
shown that autophagy is involved in the delivery of various antigens
(viral, self, and tumor origin) to MHC class II antigen-presenting
molecules, which can in turn lead to the activation of CD4+ T
lymphocytes (Levine and Kroemer, 2008). As an example, the delivery
of Epstein–Barr viral antigens to MHC class II-loading compartment
(also known as late endosomes), prior to CD4+ T cell stimulation, has
been shown to utilize the autophagy mechanism (Paludan et al.,
2005). Constitutive autophagy in immune and epithelial cells has also
been observed to participate in the delivery of LC3-tagged inﬂuenza
matrix proteins to MHC class II-associated endosomal compartments,
which resulted in enhanced antigen presentation to CD4+ T cells
(Schmid et al., 2007). Furthermore, the importance of autophagy-
mediated class II antigen presentation was recently demonstrated in
the regulation of HSV-1 pathogenesis by viral ICP34.5 (Leib et al.,
2009). As well, it has been shown that the immunization of mice
with inﬂuenza A (IFA)-infected cells exhibiting enhanced autophagy
facilitates more robust MHC class I antigen presentation to the CD8+
T cells (Uhl et al., 2009). This evidence suggests that autophagy
may contribute to MHC class I/II-speciﬁc viral antigen presentation,aiding the induction of adaptive immune responses. These studies
also raise the exciting possibility that it may be feasible to exploit
autophagy to deliver viral antigens and enhance MHC class I/II
presentation for the development of novel vaccines and adjuvant
therapies (Schmid et al., 2007).
The autophagy machinery has also been suggested to play a role
in innate immunity by delivering PAMPs to their associated PRRs,
including the TLRs. TLRs play critical roles in detecting bacterial and
viral signatures and in eliciting appropriate host cell defenses such
as IFNs and inﬂammatory cytokines against bacterial and viral
infections (Takeuchi and Akira, 2007). It has been recently shown
that the delivery of viral nucleic acids to endosomal TLRs in
plasmacytoid dendritic cells (pDCs) can occur through the autop-
hagosomes (Lee et al., 2007). While most TLRs reside on the cell
surface, a subset involved in the detection of viral gene products,
including TLR3, 7/8, and 9, is located in endosomal compartments
and aids in the detection of endocytosed viral material (Barton,
2007). Autophagosomes could theoretically facilitate the seques-
tration, delivery, and detection of cytoplasmic viral nucleic acids,
thereby helping to elicit a classical IFN response (Levine and Deretic,
2007). Indeed, autophagy has been shown to mediate ssRNA virus
recognition through TLR7 during vesicular stomatitis virus (VSV)
and Sendai virus (SENV) infection. It contributes to the production
of interferon-α by pDCs in vitro and in vivo (Lee et al., 2007). Hence,
this intrinsic pathway may play an important role in the detection
of viral antigens and in the induction of the subsequent IFN response
in pDCs.
More recently, evidence supporting the involvement of au-
tophagy in the TLR-related detection of viral PAMPs has increased
with the ﬁnding that TLRs themselves can induce autophagosome
formation. This suggests a potential feedback circuit involving
autophagy in the pathogen-triggered immune response. Lipopoly-
saccharide (LPS)-induced autophagy has been demonstrated in
both murine and human macrophages, and requires the TRIF (Toll-
interleukin-1 receptor domain-containing adaptor-inducing IFN-β)-
dependent TLR4 pathway, whose downstream components include
the receptor-interacting protein (RIP1) and the p38 MAPK (Xu et al.,
2007). While the physiological importance of this TLR-mediated
induction is currently unclear, it suggests that TLR4 can induce
autophagy, which may help to limit the spread of pathogenic
infections. More importantly, it appears that there is cross-talk
between the two pathways and that the autophagic machinery may
be regulated by TLRs. TLR3 (dsRNA recognition), TLR7/8 (ssRNA
recognition), and TLR9 (recognizes dsDNA with unmethylated CpG
motifs) can identify viral signatures (Kawai and Akira, 2006). TLR4
can also recognize mouse mammary tumor virus (MMTV) envelope
protein (Rassa et al., 2002) and the respiratory syncytial virus (RSV)
fusion protein (Kurt-Jones et al., 2000). In addition, TLR2 recognizes
the envelope proteins of HSV-1 (Kurt-Jones et al., 2004) and human
cytomegalovirus (Compton et al., 2003), as well as the measles virus
hemagglutinin (Bieback et al., 2002). As many of these TLRs share
downstream adaptors TRIF and myeloid differentiation primary
response gene (88) (MyD88) (Kawai and Akira, 2006), it is possible
that apart from TLR4, other TLRs may also trigger autophagy.
On the other hand, autophagy has also been suggested to sup-
press the innate immune response to VSV infection. The retinoic-acid-
inducible gene I (RIG-I)-mediated recognition of VSV in murine
ﬁbroblasts is inhibited by over-expression of Atg12–Atg5 (Jounai
et al., 2007). Furthermore, MEFs deﬁcient in Atg5 or Atg7 are resis-
tant to VSV infection, more sensitive to polyinosinic:polycytidylic
acid (poly:IC) treatment, and produce higher type I IFN responses
following either treatment (Jounai et al., 2007; Tal et al., 2009).
This evidence suggests that autophagy's effects are likely both cell-
type- and PRR-dependent, and further demonstrates the intricate
nature of the relationship between autophagy and host cell innate
immunity.
7MinireviewViruses can modulate autophagy to determine cell fate by either
postponing or hastening cell death
Autophagy is involved with many biological pathways linked
to cellular stress, and the signals that drive the activation of autoph-
agy may ultimately decide the fate of the cell. Indeed, it has been
suggested that autophagy possesses a dual role in mediating
cell survival and cell death. As a survival mechanism, autophagy sus-
tains cell viability during brief periods of cellular stress, either by
providing metabolic substrates in times of shortage, or by removing
damaged organelles in order to prevent apoptosis. On the other
hand, autophagy has also been shown to induce cellular death
under certain circumstances, which has been characterized as a form
of programmed cell death (type II PCD) that differs from the
more classical apoptotic (type I PCD) and necrotic forms of cell
death (Levine and Yuan, 2005). Inhibition of autophagy can trigger
apoptosis under starvation conditions (Boya et al., 2005), whereas
cells deﬁcient in the pro-apoptotic Bax and Bak proteins undergo
autophagic cell death upon treatment with strong pharmacological
agents such as etoposide (Shimizu et al., 2004). More importantly,
based on autophagy's dual nature with regards to cell fate, it has been
suggested that this pathway might have important roles in the
development of cancer and tumor suppression (Baehrecke, 2005;
Gozuacik and Kimchi, 2007; Kondo et al., 2005; Levine and Yuan,
2005) (Brech et al., 2009; Eisenberg-Lerner et al., 2009; Maiuri et al.,
2009; Morselli et al., 2009; Scarlatti et al., 2009).
Recent studies indicate that autophagy may function as a pro-
survival mechanism during viral infections. Autophagy has been
suggested to extend the survival time of human parvovirus B19-
infected erythroid cells during viral expansion (Nakashima et al.,
2006). Furthermore, protection against SINV-induced neuronal
apoptosis and encephalitis in mice is conferred by concurrent over-
expression of Beclin-1, but not anti-apoptotic Bcl-2 (Liang et al.,
1998). The hepatitis B virus (HBV)-encoded transcriptional transacti-
vator protein X (HBx) has been shown to up-regulate the expression
of Beclin-1 and stimulate autophagy (Tang et al., 2009), an effect
that was also observed in HBV-associated hepatocellular carcinomas
(HCC) (Song et al., 2004). Interestingly, HBx has long been suggested
to be tumorigenic (Kim et al., 1991), while Beclin-1 is commonly
regarded as a haplo-insufﬁcient tumor suppressor gene (Qu et al.,
2003; Yue et al., 2003). Hence, autophagy could be up-regulated by
HBV to prolong cell survival, and this process may help initiate the
development of HCC through an as yet uncharacterized mechanism.
As previously indicated, autophagy has been theorized to induce a
novel form of programmed cell death, particularly under circum-
stances when apoptosis is impaired. Hence, while autophagy has been
generally characterized as a pro-survival mechanism, certain viruses
may counter-intuitively block this process in order to prolong the
survival of infected cells. The Kaposi's sarcoma-associated herpesvirus
(KSHV)-encoded viral Bcl-2 (vBcl-2) protein inhibits autophagy
through its interaction with Beclin-1 (Pattingre et al., 2005) and
similar effects have also been observed with the closely related
murine γ-herpesvirus-68 (γHV-68)-encoded vBcl-2 molecule M11
(Ku et al., 2008; Sinha et al., 2008). However, in addition to their
effects on autophagy, vBcl-2s from γ-herpesviruses also protect
infected cells from apoptosis (Choi et al., 2001; Moore and Chang,
2003). While some authors have suggested that vBcl-2 help γ-
herpesviruses escape autophagic degradation (Pattingre et al., 2005),
given the powerful anti-apoptotic role of vBcl-2 it is difﬁcult to gauge
the relative importance of these effects. More recently, the KSHV viral
FADD-like interleukin-1-β-converting enzyme (FLICE)/caspase-8-
inhibitory protein (vFLIP) was shown to suppress autophagy by
interfering with the processing of LC3, and that this effect abrogated
autophagy-associated cell death in infected cells (Lee et al., 2009).
Interestingly, viral infections have also been documented to trig-
ger autophagy speciﬁcally as mechanism of inducing cell death inuninfected bystander cell populations. During HIV infection, expres-
sion of HIV envelope glycoproteins (gp120 and gp41, collectively
termed “Env”) induces autophagy in uninfected bystander CD4+ T
lymphocytes, which results in a novel cell death program with
characteristics of both type I and type II PCD (Espert et al., 2006). Thus,
it has been suggested that this autophagy-mediated phenomenon
may be signiﬁcant in contributing to general CD4+ T cell losses during
the course of HIV infections (Espert et al., 2006, 2007; Levine and
Sodora, 2006). Similarly, HIV gp120 could also enhance autophagy in
uninfected neuronal cells, leading to neuronal cell death and
potentially contributing to HIV-associated dementia (Spector and
Zhou, 2008). Interestingly, in plants, autophagy has been shown to
protect bystander non-infected cells from cell death induced by
Tobacco mosaic virus (TMV) infection (Liu et al., 2005).
The observed differential regulation of autophagy by viral
infection in controlling cellular fate provides some indication to the
potential complexity of this intrinsic pathway. It is important to note
that it is inherently difﬁcult to distinguish between autophagy as a
mechanism of virally induced cell death and a cellular response to
infection. Furthermore, there is potential that this may be a pathway
whose biology is commonly modiﬁed in laboratory cancer cell lines
used in virology research (Baird et al., 2008). For example, autophagy
has been suggested to regulate the death of brain tumor and prostate
cancer cell models infected with engineered adenoviruses (Alonso
et al., 2008; Ito et al., 2006; Jiang et al., 2007; Rajecki et al., 2009;
Ulasov et al., 2009; Yokoyama et al., 2008), but conﬂicting results
have also suggested that this response may actually be an attempt at
survival (Baird et al., 2008). Moreover, as characteristics of both type
I and type II PCD are often seen in conjunction, it is often difﬁcult
to differentiate whether the observed phenomenon is an execu-
tioner mechanism or a futile attempt at cell survival. Nonetheless,
from the above discussions it is clear that autophagy can contribute
in the regulation of cellular fate, and as such may be speciﬁcally
regulated by viruses to promote their life cycle.
Discussion
Questions regarding how viral infections interact with, and are
impacted by, the autophagy pathway are increasingly gaining
prominence within virology. While this relatively new area of
research has produced a number of exciting results, limits in our
understanding of the mechanism, its regulation, and in the available
investigative tools continue to present challenges, as would be
expected in any emerging area of research. One complexity for
researchers is that the regulation of autophagy is intimately inter-
connected with cellular growth and survival, as well as numerous
cellular stress responses. Hence, considerable caution should be
exercised before an effect on viral replication is directly attributed
to this pathway. Furthermore, the natural complexity and diversity
of viral pathogens and their host cells has resulted in numerous
conﬂicting observations, making it difﬁcult to draw clear and
concise conclusions regarding the general role of autophagy in viral
infections.
Despite these and other challenges, there is increasing evidence
that this ancient cellular process is a signiﬁcant factor in the fate of
numerous different viral infections. During poliovirus infection,
autophagy promotes viral replication through its most primitive
function: the ability to induce membrane remodeling and vesicle
formation. The processes of xenophagy and immune surveillance via
cytoplasmic sampling suggest that autophagymay have evolved to act
as a defense against intracellular pathogens that viruses must now
contend with. Finally, autophagy's interconnections with cell death
programs ingrain it in processes that ultimately determine cellular
fate, suggesting that viruses may modulate it to inﬂuence cell sur-
vival and ensure their own reproductive advantage. Thus, autoph-
agy may be implicated in the biological pathogenesis and/or
8 Minireviewreplicative success of many viral infections through a wide variety of
possible mechanisms, and can exhibit multiple distinct and cell-type-
dependent roles in the course of a single viral infection. This is best
illustrated in the case of HIV, where the autophagy machinery is: 1)
down-regulated in virally-infected CD4+ T cells (Espert et al., 2009;
Zhou and Spector, 2008), which may constitute a strategy
for avoiding autophagosome-mediated degradation and/or endoso-
mal detection in order to enhance virion production; 2) engaged in
HIV-infected macrophages to promote virion production (Kyei et al.,
2009); and 3) activated in bystander neurological and immu-
nological naïve cells to commit cell death by type II PCD, thereby
contributing to HIV pathogenesis (CD4+ T cell depletion and
neuronal death associated-dementia) (Espert et al., 2006).
The revelation that autophagy can function in immune defense of
the host cells, particularly relating to innate immunity, suggests
reciprocal regulation (through TLRs and IFN response) aiding in the
subsequent development of an adaptive immune response (through
enhancement of MHC presentation) to clear pathogens in infected
tissues. Further research has the potential to reveal unknown protein
interactions and could lead to the development of new pharma-
cological therapies for treating various virally induced diseases and
associated cancers. As new research tools emerge, continuing research
will help to clarify the role of autophagy in viral replication, host
immune responses, and viral pathogenesis. The intricacies of viral
interactions with this ancient and highly conserved pathway strongly
suggest that autophagy can function in a myriad of ways, some of
which appear contradictory at ﬁrst glance. Depending upon the
circumstances, autophagy can be pro-survival or pro-death, can
enhance viral replication or aid in the development of the antiviral
response. Autophagy is a double-edged sword that can cut both ways.
Clearly a virus would prefer to be on autophagy's good side!!Acknowledgments
The authors would like to apologize to any investigators whose
works were not included during the publication of this work due to
space limitation. The authors would also like to thank Dr. Ryan S.
Noyce for his critical reading of the manuscript, and Ting-Fen Chin for
her technical assistance with Fig. 1. L.-T. Lin is a recipient of the
National CIHR Research Training Program in Hepatitis C (NCRTP-
HepC) fellowship. P.W.H. Dawson is a recipient of a Frederick Banting
and Charles Best master's award from the Canadian Institutes of
Health Research (CIHR).References
Ait-Goughoulte, M., Kanda, T., Meyer, K., Ryerse, J.S., Ray, R.B., Ray, R., 2008. Hepatitis C
virus genotype 1a growth and induction of autophagy. J. Virol. 82 (5), 2241–2249.
Alexander, D.E., Leib, D.A., 2008. Xenophagy in herpes simplex virus replication and
pathogenesis. Autophagy 4 (1), 101–103.
Alexander, D.E., Ward, S.L., Mizushima, N., Levine, B., Leib, D.A., 2007. Analysis of the
role of autophagy in replication of herpes simplex virus in cell culture. J. Virol. 81
(22), 12128–12134.
Alirezaei, M., Kiosses, W., Flynn, C., Brady, N., Fox, H., 2008. Disruption of neuronal
autophagy by infected microglia results in neurodegeneration. PLoS ONE 3 (8),
e2906.
Alonso, M.M., Jiang, H., Yokoyama, T., Xu, J., Bekele, N., Lang, F.F., Kondo, S., Gomez-
Manzano, C., Fueyo, J., 2008. Delta-24-RGD in combination with RAD001 induces
enhanced anti-glioma effect via autophagic cell death. Mol. Ther. 16 (3),
487–493.
Amer, A.O., Swanson, M.S., 2005. Autophagy is an immediate macrophage response to
Legionella pneumophila. Cell. Microbiol. 7 (6), 765–778.
Arsham, A.M., Neufeld, T.P., 2006. Thinking globally and acting locally with TOR. Curr.
Opin. Cell Biol. 18 (6), 589–597.
Baehrecke, E.H., 2005. Autophagy: dual roles in life and death? Nat. Rev. Mol. Cell Biol. 6
(6), 505–510.
Baird, S., Aerts, J., Eddaoudi, A., Lockley, M., Lemoine, N., Mcneish, I., 2008. Oncolytic
adenoviral mutants induce a novel mode of programmed cell death in ovarian
cancer. Oncogene 27 (22), 3081–3090.
Barton,G.M., 2007. Viral recognitionbyToll-like receptors. Semin. Immunol. 19 (1), 33–40.Belov, G.A., Altan-Bonnet, N., Kovtunovych, G., Jackson, C.L., Lippincott-Schwartz, J.,
Ehrenfeld, E., 2007. Hijacking components of the cellular secretory pathway for
replication of poliovirus RNA. J. Virol. 81 (2), 558–567.
Beugnet, A., Tee, A., Taylor, P., Proud, C., 2003. Regulation of targets of mTOR
(mammalian target of rapamycin) signalling by intracellular amino acid availabil-
ity. Biochem. J. 372 (Pt 2), 555–566.
Bieback, K., Lien, E., Klagge, I.M., Avota, E., Schneider-Schaulies, J., Duprex, W.P.,
Wagner, H., Kirschning, C.J., Ter Meulen, V., Schneider-Schaulies, S., 2002.
Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2
signaling. J. Virol. 76 (17), 8729–8736.
Bienz, K., Egger, D., Pasamontes, L., 1987. Association of polioviral proteins of the P2
genomic region with the viral replication complex and virus-induced membrane
synthesis as visualized by electron microscopic immunocytochemistry and
autoradiography. Virology 160 (1), 220–226.
Boya, P., González-Polo, R.A., Casares, N., Perfettini, J.L., Dessen, P., Larochette, N.,
Métivier, D., Meley, D., Souquere, S., Yoshimori, T., Pierron, G., Codogno, P.,
Kroemer, G., 2005. Inhibition of macroautophagy triggers apoptosis. Mol. Cell. Biol.
25 (3), 1025–1040.
Brabec-Zaruba, M., Berka, U., Blaas, D., Fuchs, R., 2007. Induction of autophagy does not
affect human rhinovirus type 2 production. J. Virol. 81 (19), 10815–10817.
Brech, A., Ahlquist, T., Lothe, R.A., Stenmark, H., 2009. Autophagy in tumour suppression
and promotion. Mol. Oncol. 3 (4), 366–375.
Chaumorcel, M., Souquère, S., Pierron, G., Codogno, P., Esclatine, A., 2008. Human
cytomegalovirus controls a new autophagy-dependent cellular antiviral defense
mechanism. Autophagy 4 (1), 46–53.
Cherry, S., Kunte, A., Wang, H., Coyne, C., Rawson, R., Perrimon, N., 2006. COPI activity
coupled with fatty acid biosynthesis is required for viral replication. PLoS Pathog 2
(10), e102.
Choi, J., Means, R.E., Damania, B., Jung, J.U., 2001. Molecular piracy of Kaposi's sarcoma
associated herpesvirus. Cytokine Growth Factor Rev. 12 (2–3), 245–257.
Codogno, P., Meijer, A.J., 2005. Autophagy and signaling: their role in cell survival and
cell death. Cell Death Differ. 12 (Suppl 2), 1509–1518.
Compton, T., Kurt-Jones, E.A., Boehme, K.W., Belko, J., Latz, E., Golenbock, D.T., Finberg,
R.W., 2003. Human cytomegalovirus activates inﬂammatory cytokine responses via
CD14 and Toll-like receptor 2. J. Virol. 77 (8), 4588–4596.
de Haan, C.A., Reggiori, F., 2008. Are nidoviruses hijacking the autophagy machinery?
Autophagy 4 (3), 276–279.
Delgado, M.A., Deretic, V., 2009. Toll-like receptors in control of immunological
autophagy. Cell Death Differ. 16 (7), 976–983.
Delgado, M., Singh, S., De Haro, S., Master, S., Ponpuak, M., Dinkins, C., Ornatowski, W.,
Vergne, I., Deretic, V., 2009. Autophagy and pattern recognition receptors in innate
immunity. Immunol. Rev. 227 (1), 189–202.
Deretic, V., 2005. Autophagy in innate and adaptive immunity. Trends Immunol. 26
(10), 523–528.
Ding, W.-X., Ni, H.-M., Gao, W., Hou, Y.-F., Melan, M.A., Chen, X., Stolz, D.B., Shao, Z.-M.,
Yin, X.-M., 2007. Differential effects of endoplasmic reticulum stress-induced
autophagy on cell survival. J. Biol. Chem. 282 (7), 4702–4710.
Djavaheri-Mergny, M., Amelotti, M., Mathieu, J., Besançon, F., Bauvy, C., Souquère, S.,
Pierron, G., Codogno, P., 2006. NF-kappaB activation represses tumor necrosis
factor-alpha-induced autophagy. J. Biol. Chem. 281 (41), 30373–30382.
Djavaheri-Mergny, M., Amelotti, M., Mathieu, J., Besançon, F., Bauvy, C., Codogno, P.,
2007. Regulation of autophagy by NFkappaB transcription factor and reactives
oxygen species. Autophagy 3 (4), 390–392.
Dreux, M., Gastaminza, P., Wieland, S.F., Chisari, F.V., 2009. The autophagy machinery is
required to initiate hepatitis C virus replication. Proc. Natl. Acad. Sci. U. S. A. 106
(33), 14046–14051.
Eisenberg-Lerner, A., Bialik, S., Simon, H., Kimchi, A., 2009. Life and death partners:
apoptosis, autophagy and the cross-talk between them. Cell Death Differ. 16 (7),
966–975.
English, L., Chemali, M., Duron, J., Rondeau, C., Laplante, A., Gingras, D., Alexander, D.,
Leib, D., Norbury, C., Lippé, R., Desjardins, M., 2009. Autophagy enhances the
presentation of endogenous viral antigens on MHC class I molecules during HSV-1
infection. Nat Immunol 10 (5), 480–487.
Espert, L., Denizot, M., Grimaldi, M., Robert-Hebmann, V., Gay, B., Varbanov, M.,
Codogno, P., Biard-Piechaczyk, M., 2006. Autophagy is involved in T cell death after
binding of HIV-1 envelope proteins to CXCR4. J. Clin. Invest. 116 (8), 2161–2172.
Espert, L., Denizot, M., Grimaldi, M., Robert-Hebmann, V., Gay, B., Varbanov, M.,
Codogno, P., Biard-Piechaczyk, M., 2007. Autophagy and CD4+ T lymphocyte
destruction by HIV-1. Autophagy 3 (1), 32–34.
Espert, L., Varbanov, M., Robert-Hebmann, V., Sagnier, S., Robbins, I., Sanchez, F., Lafont,
V., Biard-Piechaczyk, M., 2009. Differential role of autophagy in CD4 T cells and
macrophages during X4 and R5 HIV-1 infection. PLoS ONE 4 (6), e5787.
Ferraro, E., Cecconi, F., 2007. Autophagic and apoptotic response to stress signals in
mammalian cells. Arch. Biochem. Biophys. 462 (2), 210–219.
Gannagé, M., Dormann, D., Albrecht, R., Dengjel, J., Torossi, T., Rämer, P.C., Lee, M.,
Strowig, T., Arrey, F., Conenello, G., Pypaert, M., Andersen, J., García-Sastre, A.,
Münz, C., 2009. Matrix protein 2 of inﬂuenza A virus blocks autophagosome fusion
with lysosomes. Cell Host Microbe 6 (4), 367–380.
Gordon, P.B., Holen, I., Fosse, M., Røtnes, J.S., Seglen, P.O., 1993. Dependence of
hepatocytic autophagy on intracellularly sequestered calcium. J. Biol. Chem. 268
(35), 26107–26112.
Gozuacik, D., Kimchi, A., 2007. Autophagy and cell death. Curr. Top. Dev. Biol. 78,
217–245.
Gutierrez, M.G., Master, S.S., Singh, S.B., Taylor, G.A., Colombo, M.I., Deretic, V., 2004.
Autophagy is a defense mechanism inhibiting BCG andMycobacterium tuberculosis
survival in infected macrophages. Cell 119 (6), 753–766.
9MinireviewHe, B., Gross, M., Roizman, B., 1997. The gamma(1)34.5 protein of herpes simplex virus
1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha
subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of
protein synthesis by double-stranded RNA-activated protein kinase. Proc. Natl.
Acad. Sci. U. S. A. 94 (3), 843–848.
Høyer-Hansen, M., Jäättelä, M., 2007. Connecting endoplasmic reticulum stress to
autophagy by unfolded protein response and calcium. Cell Death Differ. 14 (9),
1576–1582.
Huang, S., Chang, C., Wang, P., Tsai, Y., Liu, H., 2009. Enterovirus 71-induced autophagy
detected in vitro and invivopromotes viral replication. J.Med.Virol. 81 (7), 1241–1252.
Ito, H., Aoki, H., Kühnel, F., Kondo, Y., Kubicka, S., Wirth, T., Iwado, E., Iwamaru, A.,
Fujiwara, K., Hess, K.R., Lang, F.F., Sawaya, R., Kondo, S., 2006. Autophagic cell death
of malignant glioma cells induced by a conditionally replicating adenovirus. Cancer
Spectr. Knowl. Environ. 98 (9), 625–636.
Itzhaki, R.F., Cosby, S., Wozniak, M.A., 2008. Herpes simplex virus type 1 and
Alzheimer's disease: the autophagy connection. J. Neurovirol. 14 (1), 1–4.
Jackson, W., Giddings, T., Taylor, M., Mulinyawe, S., Rabinovitch, M., Kopito, R.,
Kirkegaard, K., 2005. Subversion of cellular autophagosomal machinery by RNA
viruses. Plos Biol. 3 (5), e156.
Jiang, H., Gomez-Manzano, C., Aoki, H., Alonso, M.M., Kondo, S., McCormick, F., Xu, J.,
Kondo, Y., Bekele, B.N., Colman, H., Lang, F.F., Fueyo, J., 2007. Examination of the
therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic
cell death. Cancer Spectr. Knowl. Environ. 99 (18), 1410–1414.
Jounai, N., Takeshita, F., Kobiyama, K., Sawano, A., Miyawaki, A., Xin, K.Q., Ishii, K.J.,
Kawai, T., Akira, S., Suzuki, K., Okuda, K., 2007. The Atg5 Atg12 conjugate associates
with innate antiviral immune responses. Proc. Natl. Acad. Sci. U. S. A. 104 (35),
14050–14055.
Kawai, T., Akira, S., 2006. Innate immune recognition of viral infection. Nat. Immunol. 7
(2), 131–137.
Khakpoor, A., Panyasrivanit, M., Wikan, N., Smith, D.R., 2009. A role for autophagolyso-
somes in dengue virus 3 production in HepG2 cells. J. Gen. Virol. 90 (Pt 5),
1093–1103.
Kim, C.M., Koike, K., Saito, I., Miyamura, T., Jay, G., 1991. HBx gene of hepatitis B virus
induces liver cancer in transgenic mice. Nature 351 (6324), 317–320.
Kirkegaard, K., Taylor, M., Jackson, W., 2004. Cellular autophagy: surrender, avoidance
and subversion by microorganisms. Nat. Rev. Microbiol. 2 (4), 301–314.
Klionsky, D.J., Abeliovich, H., Agostinis, P., Agrawal, D.K., Aliev, G., Askew, D.S., Baba, M.,
Baehrecke, E.H., Bahr, B.A., Ballabio, A., Bamber, B.A., Bassham,D.C., Bergamini, E., Bi, X.,
Biard-Piechaczyk, M., Blum, J.S., Bredesen, D.E., Brodsky, J.L., Brumell, J.H., Brunk, U.T.,
Bursch,W., Camougrand, N., Cebollero, E., Cecconi, F., Chen, Y., Chin, L.-S., Choi, A., Chu,
C.T., Chung, J., Clarke, P.G.H., Clark, R.S.B., Clarke, S.G., Clavé, C., Cleveland, J.L., Codogno,
P., Colombo, M.I., Coto-Montes, A., Cregg, J.M., Cuervo, A.M., Debnath, J., Demarchi, F.,
Dennis, P.B., Dennis, P.A., Deretic, V., Devenish, R.J., Di Sano, F., Dice, J.F., Diﬁglia, M.,
Dinesh-Kumar, S., Distelhorst, C.W., Djavaheri-Mergny, M., Dorsey, F.C., Dröge, W.,
Dron, M., Dunn,W.A., Duszenko,M., Eissa, N.T., Elazar, Z., Esclatine, A., Eskelinen, E.-L.,
Fésüs, L., Finley, K.D., Fuentes, J.M., Fueyo, J., Fujisaki, K., Galliot, B., Gao, F.-B., Gewirtz,
D.A., Gibson, S.B., Gohla, A., Goldberg, A.L., Gonzalez, R., González-Estévez, C., Gorski, S.,
Gottlieb, R.A., Häussinger, D., He, Y.-W., Heidenreich, K., Hill, J.A., Høyer-Hansen, M.,
Hu, X., Huang,W.-P., Iwasaki, A., Jäättelä,M., Jackson,W.T., Jiang, X., Jin, S., Johansen, T.,
Jung, J.U., Kadowaki, M., Kang, C., Kelekar, A., Kessel, D.H., Kiel, J.A.K.W., Kim, H.P.,
Kimchi, A., Kinsella, T.J., Kiselyov, K., Kitamoto, K., Knecht, E., Komatsu, M., Kominami,
E., Kondo, S., Kovács, A.L., Kroemer, G., Kuan, C.-Y., Kumar, R., Kundu, M., Landry, J.,
Laporte,M., Le,W., Lei, H.-Y., Lenardo,M.J., Levine, B., Lieberman,A., Lim,K.-L., Lin, F.-C.,
Liou,W., Liu, L.F., Lopez-Berestein, G., López-Otín, C., Lu, B., Macleod, K.F., Malorni, W.,
Martinet,W.,Matsuoka,K.,Mautner, J.,Meijer, A.J.,Meléndez, A.,Michels, P.,Miotto, G.,
Mistiaen, W.P., Mizushima, N., Mograbi, B., Monastyrska, I., Moore, M.N., Moreira, P.I.,
Moriyasu, Y., Motyl, T., Münz, C., Murphy, L.O., Naqvi, N.I., Neufeld, T.P., Nishino, I.,
Nixon, R.A., Noda, T., Nürnberg, B., Ogawa, M., Oleinick, N.L., Olsen, L.J., Ozpolat, B.,
Paglin, S., Palmer, G.E., Papassideri, I., Parkes, M., Perlmutter, D.H., Perry, G., Piacentini,
M., Pinkas-Kramarski, R., Prescott, M., Proikas-Cezanne, T., Raben, N., Rami, A.,
Reggiori, F., Rohrer, B., Rubinsztein, D.C., Ryan, K.M., Sadoshima, J., Sakagami, H., Sakai,
Y., Sandri, M., Sasakawa, C., Sass, M., Schneider, C., Seglen, P.O., Seleverstov, O.,
Settleman, J., Shacka, J.J., Shapiro, I.M., Sibirny, A., Silva-Zacarin, E.C.M., Simon, H.-U.,
Simone, C., Simonsen, A., Smith, M.A., Spanel-Borowski, K., Srinivas, V., Steeves, M.,
Stenmark, H., Stromhaug, P.E., Subauste, C.S., Sugimoto, S., Sulzer, D., Suzuki, T.,
Swanson, M.S., Tabas, I., Takeshita, F., Talbot, N.J., Tallóczy, Z., Tanaka, K., Tanaka, K.,
Tanida, I., Taylor, G.S., Taylor, J.P., Terman, A., Tettamanti, G., Thompson, C.B., Thumm,
M., Tolkovsky, A.M., Tooze, S.A., Truant, R., Tumanovska, L.V., Uchiyama, Y., Ueno, T.,
Uzcátegui, N.L., van der Klei, I., Vaquero, E.C., Vellai, T., Vogel, M.W., Wang, H.-G.,
Webster, P., Wiley, J.W., Xi, Z., Xiao, G., Yahalom, J., Yang, J.-M., Yap, G., Yin, X.-M.,
Yoshimori, T., Yu, L., Yue, Z., Yuzaki,M., Zabirnyk,O., Zheng,X., Zhu,X., Deter, R.L., 2008.
Guidelines for the use and interpretation of assays formonitoring autophagy inhigher
eukaryotes. Autophagy 4 (2), 151–175.
Kondo, Y., Kanzawa, T., Sawaya, R., Kondo, S., 2005. The role of autophagy in cancer
development and response to therapy. Nat. Rev. Cancer 5 (9), 726–734.
Kouroku, Y., Fujita, E., Tanida, I., Ueno, T., Isoai, A., Kumagai, H., Ogawa, S., Kaufman, R.J.,
Kominami, E., Momoi, T., 2007. ER stress (PERK/eIF2alpha phosphorylation)
mediates the polyglutamine-induced LC3 conversion, an essential step for
autophagy formation. Cell Death Differ. 14 (2), 230–239.
Kroemer, G., Levine, B., 2008. Autophagic cell death: the story of a misnomer. Nat. Rev.
Mol. Cell Biol. 9 (12), 1004–1010.
Ku, B., Woo, J., Liang, C., Lee, K., Hong, H., Xiaofei, E., Kim, K., Jung, J., Oh, B., 2008.
Structural and biochemical bases for the inhibition of autophagy and apoptosis by
viral BCL-2 of murine gamma-herpesvirus 68. PLoS Pathog. 4 (2), e25.
Kurt-Jones, E.A., Popova, L., Kwinn, L., Haynes, L.M., Jones, L.P., Tripp, R.A., Walsh, E.E.,
Freeman, M.W., Golenbock, D.T., Anderson, L.J., Finberg, R.W., 2000. Patternrecognition receptors TLR4 and CD14 mediate response to respiratory syncytial
virus. Nat. Immunol. 1 (5), 398–401.
Kurt-Jones, E.A., Chan,M., Zhou, S.,Wang, J., Reed,G., Bronson,R., Arnold,M.M., Knipe,D.M.,
Finberg, R.W., 2004. Herpes simplex virus 1 interaction with Toll-like receptor 2
contributes to lethal encephalitis. Proc. Natl. Acad. Sci. U. S. A. 101 (5), 1315–1320.
Kyei, G.B., Dinkins, C., Davis, A.S., Roberts, E., Singh, S.B., Dong, C., Wu, L., Kominami, E.,
Ueno, T., Yamamoto, A., Federico, M., Panganiban, A., Vergne, I., Deretic, V., 2009.
Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in
macrophages. J. Cell Biol. 186 (2), 255–268.
Lee, H.K., Lund, J.M., Ramanathan, B., Mizushima, N., Iwasaki, A., 2007. Autophagy-
dependent viral recognition by plasmacytoid dendritic cells. Science 315 (5817),
1398–1401.
Lee, D., Sugden, B., 2008. The latent membrane protein 1 oncogene modiﬁes B-cell
physiology by regulating autophagy. Oncogene 27 (20), 2833–2842.
Lee, Y.R., Lei, H.Y., Liu, M.T., Wang, J.R., Chen, S.H., Jiang-Shieh, Y.F., Lin, Y.S., Yeh, T.M.,
Liu, C.C., Liu, H., 2008. Autophagic machinery activated by dengue virus enhances
virus replication. Virology 374 (2), 240–248.
Lee, J., Li, Q., Lee, J., Lee, S., Jeong, J., Lee, H., Chang, H., Zhou, F., Gao, S., Liang, C., Jung, J.,
2009. FLIP-mediated autophagy regulation in cell death control. Nat. Cell Biol. 11
(11), 1355–1362.
Leib, D.A., Alexander, D.E., Cox, D., Yin, J., Ferguson, T.A., 2009. Interaction of ICP34.5
with Beclin 1 modulates herpes simplex virus type 1 pathogenesis through control
of CD4+ T-cell responses. J. Virol. 83 (23), 12164–12171.
Levine, B., 2005. Eating oneself and uninvited guests: autophagy-related pathways in
cellular defense. Cell 120 (2), 159–162.
Levine, B., Deretic, V., 2007. Unveiling the roles of autophagy in innate and adaptive
immunity. Nat. Rev. Immunol. 7 (10), 767–777.
Levine, B., Kroemer, G., 2008. Autophagy in the pathogenesis of disease. Cell 132 (1),
27–42.
Levine, B., Sodora, D.L., 2006. HIV and CXCR4 in a kiss of autophagic death. J. Clin. Invest.
116 (8), 2078–2080.
Levine, B., Yuan, J., 2005. Autophagy in cell death: an innocent convict? J. Clin. Invest.
115 (10), 2679–2688.
Liang, X.H., Kleeman, L.K., Jiang, H.H., Gordon, G., Goldman, J.E., Berry, G., Herman, B.,
Levine, B., 1998. Protection against fatal Sindbis virus encephalitis by beclin, a novel
Bcl-2-interacting protein. J. Virol. 72 (11), 8586–8596.
Liu, Y., Schiff, M., Czymmek, K., Tallóczy, Z., Levine, B., Dinesh-Kumar, S.P., 2005.
Autophagy regulates programmed cell death during the plant innate immune
response. Cell 121 (4), 567–577.
Longatti, A., Tooze, S.A., 2009. Vesicular trafﬁcking and autophagosome formation. Cell
Death Differ. 16 (7), 956–965.
Maiuri, M., Zalckvar, E., Kimchi, A., Kroemer, G., 2007. Self-eating and self-killing:
crosstalk between autophagy and apoptosis. Nat. Rev. Mol. Cell Biol. 8 (9), 741–752.
Maiuri, M., Tasdemir, E., Criollo, A., Morselli, E., Vicencio, J., Carnuccio, R., Kroemer, G.,
2009. Control of autophagy by oncogenes and tumor suppressor genes. Cell Death
Differ. 16 (1), 87–93.
Meijer, A.J., Codogno, P., 2004. Regulation and role of autophagy in mammalian cells.
Int. J. Biochem. Cell Biol. 36 (12), 2445–2462.
Meijer, A.J., Codogno, P., 2006. Signalling and autophagy regulation in health, aging and
disease. Mol. Aspects Med. 27 (5–6), 411–425.
Mijaljica, D., Prescott, M., Devenish, R.J., 2006. Endoplasmic reticulum and Golgi
complex: contributions to, and turnover by, autophagy. Trafﬁc 7 (12), 1590–1595.
Miller, S., Krijnse-Locker, J., 2008. Modiﬁcation of intracellular membrane structures for
virus replication. Nat. Rev. Microbiol. 6 (5), 363–374.
Mizushima, N., 2004. Methods for monitoring autophagy. Int. J. Biochem. Cell Biol. 36
(12), 2491–2502.
Mizushima, N., 2007. Autophagy: process and function. Genes Dev. 21 (22), 2861–2873.
Mizushima, N., Levine, B., Cuervo, A.M., Klionsky, D., 2008. Autophagy ﬁghts disease
through cellular self-digestion. Nature 451 (7182), 1069–1075.
Moore, P.S., Chang, Y., 2003. Kaposi's sarcoma-associated herpesvirus immunoevasion
and tumorigenesis: two sides of the same coin? Annu. Rev. Microbiol. 57, 609–639.
Morselli, E., Galluzzi, L., Kepp, O., Vicencio, J.M., Criollo, A., Maiuri, M.C., Kroemer, G.,
2009. Anti- and pro-tumor functions of autophagy. Biochim. Biophys. Acta. 1793
(9), 1524–1532.
Münz, C., 2006. Autophagy and antigen presentation. Cell. Microbiol. 8 (6), 891–898.
Nakagawa, I., Amano, A., Mizushima, N., Yamamoto, A., Yamaguchi, H., Kamimoto, T., Nara,
A., Funao, J., Nakata, M., Tsuda, K., Hamada, S., Yoshimori, T., 2004. Autophagy defends
cells against invading group A Streptococcus. Science 306 (5698), 1037–1040.
Nakashima, A., Tanaka, N., Tamai, K., Kyuuma, M., Ishikawa, Y., Sato, H., Yoshimori, T.,
Saito, S., Sugamura, K., 2006. Survival of parvovirus B19-infected cells by cellular
autophagy. Virology 349 (2), 254–263.
Noda, T., Fujita, N., Yoshimori, T., 2009. The late stages of autophagy: how does the end
begin? Cell Death Differ. 16 (7), 984–990.
Ogata, M., Hino, S.-i., Saito, A., Morikawa, K., Kondo, S., Kanemoto, S., Murakami, T.,
Taniguchi, M., Tanii, I., Yoshinaga, K., Shiosaka, S., Hammarback, J.A., Urano, F.,
Imaizumi, K., 2006. Autophagy is activated for cell survival after endoplasmic
reticulum stress. Mol. Cell. Biol. 26 (24), 9220–9231.
Ogawa, M., Yoshimori, T., Suzuki, T., Sagara, H., Mizushima, N., Sasakawa, C., 2005.
Escape of intracellular Shigella from autophagy. Science 307 (5710), 727–731.
Orvedahl, A., Levine, B., 2008. Autophagy and viral neurovirulence. Cell. Microbiol. 10
(9), 1747–1756.
Orvedahl, A., Levine, B., 2009. Eating the enemy within: autophagy in infectious
diseases. Cell Death Differ. 16 (1), 57–69.
Orvedahl, A., Alexander, D., Tallóczy, Z., Sun, Q., Wei, Y., Zhang, W., Burns, D., Leib, D.A.,
Levine, B., 2007. HSV-1 ICP34.5 confers neurovirulence by targeting the Beclin 1
autophagy protein. Cell Host Microbe 1 (1), 23–35.
10 MinireviewPaludan, C., Schmid, D., Landthaler, M., Vockerodt, M., Kube, D., Tuschl, T., Münz, C., 2005.
EndogenousMHC class II processingof a viral nuclear antigen after autophagy. Science
307 (5709), 593–596.
Panyasrivanit, M., Khakpoor, A., Wikan, N., Smith, D.R., 2009. Co-localization of
constituents of the dengue virus translation and replication machinery with
amphisomes. J. Gen. Virol. 90 (Pt 2), 448–456.
Pattingre, S., Bauvy, C., Codogno, P., 2003. Amino acids interfere with the ERK1/2-
dependent control of macroautophagy by controlling the activation of Raf-1 in
human colon cancer HT-29 cells. J. Biol. Chem. 278 (19), 16667–16674.
Pattingre, S., Tassa, A., Qu, X., Garuti, R., Liang, X.H., Mizushima, N., Packer, M.,
Schneider, M.D., Levine, B., 2005. Bcl-2 antiapoptotic proteins inhibit Beclin 1-
dependent autophagy. Cell 122 (6), 927–939.
Pattingre, S., Espert, L., Biard-Piechaczyk, M., Codogno, P., 2008. Regulation of
macroautophagy by mTOR and Beclin 1 complexes. Biochimie 90 (2), 313–323.
Prentice, E., Jerome, W.G., Yoshimori, T., Mizushima, N., Denison, M.R., 2004a.
Coronavirus replication complex formation utilizes components of cellular
autophagy. J. Biol. Chem. 279 (11), 10136–10141.
Prentice, E., McAuliffe, J., Lu, X., Subbarao, K., Denison, M.R., 2004b. Identiﬁcation and
characterization of severe acute respiratory syndrome coronavirus replicase
proteins. J. Virol. 78 (18), 9977–9986.
Pujol, C., Klein,K.A., Romanov,G.A., Palmer, L.E., Cirota, C., Zhao, Z., Bliska, J.B., 2009.Yersinia
pestis can reside in autophagosomes and avoid xenophagy in murine macrophages
by preventing vacuole acidiﬁcation. Infect. Immun. 77 (6), 2251–2261.
Qu, X., Yu, J., Bhagat, G., Furuya, N., Hibshoosh, H., Troxel, A., Rosen, J., Eskelinen, E.L.,
Mizushima, N., Ohsumi, Y., Cattoretti, G., Levine, B., 2003. Promotion of
tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J. Clin.
Invest. 112 (12), 1809–1820.
Rajecki, M., Hällström, T.A., Hakkarainen, T., Nokisalmi, P., Hautaniemi, S., Nieminen, A.I.,
Tenhunen,M., Rantanen,V., Desmond,R.A., Chen,D.T.,Guse, K., Stenman,U.H., Gargini,
R., Kapanen, M., Klefström, J., Kanerva, A., Pesonen, S., Ahtiainen, L., Hemminki, A.,
2009. Mre11 inhibition by oncolytic adenovirus associates with autophagy and
underlies synergy with ionizing radiation. Int. J. Cancer 125 (10), 2441–2449.
Rassa, J.C., Meyers, J.L., Zhang, Y., Kudaravalli, R., Ross, S.R., 2002. Murine retroviruses
activate B cells via interaction with toll-like receptor 4. Proc. Natl. Acad. Sci. U. S. A.
99 (4), 2281–2286.
Reggiori, F., Klionsky, D., 2005. Autophagosomes: biogenesis from scratch? Curr. Opin.
Cell Biol. 17 (4), 415–422.
Rust, R.C., Landmann, L., Gosert, R., Tang, B.L., Hong, W., Hauri, H.P., Egger, D., Bienz, K.,
2001. Cellular COPII proteins are involved in production of the vesicles that form
the poliovirus replication complex. J. Virol. 75 (20), 9808–9818.
Scarlatti, F., Granata, R., Meijer, A.J., Codogno, P., 2009. Does autophagy have a license to
kill mammalian cells? Cell Death Differ. 16 (1), 12–20.
Scherz-Shouval, R., Elazar, Z., 2007. ROS, mitochondria and the regulation of autophagy.
Trends Cell Biol. 17 (9), 422–427.
Scherz-Shouval, R., Shvets, E., Fass, E., Shorer, H., Gil, L., Elazar, Z., 2007. Reactive oxygen
species are essential for autophagy and speciﬁcally regulate the activity of Atg4.
EMBO J. 26 (7), 1749–1760.
Schlegel, A., Giddings, T.H., Ladinsky,M.S., Kirkegaard,K., 1996. Cellular origin andultrastruc-
ture of membranes induced during poliovirus infection. J. Virol. 70 (10), 6576–6588.
Schmid, D., Münz, C., 2005. Immune surveillance of intracellular pathogens via
autophagy. Cell Death Differ. 12 (Suppl 2), 1519–1527.
Schmid, D., Pypaert, M., Münz, C., 2007. Antigen-loading compartments for major
histocompatibility complex class II molecules continuously receive input from
autophagosomes. Immunity 26 (1), 79–92.
Shelly, S., Lukinova, N., Bambina, S., Berman, A., Cherry, S., 2009. Autophagy is an
essential component of Drosophila immunity against vesicular stomatitis virus.
Immunity 30 (4), 588–598.
Shimizu, S., Kanaseki, T.,Mizushima,N.,Mizuta, T., Arakawa-Kobayashi, S., Thompson, C.B.,
Tsujimoto, Y., 2004. Role of Bcl-2 family proteins in a non-apoptotic programmed cell
death dependent on autophagy genes. Nat. Cell Biol. 6 (12), 1221–1228.
Shinojima, N., Yokoyama, T., Kondo, Y., Kondo, S., 2007. Roles of the Akt/mTOR/p70S6K
and ERK1/2 signaling pathways in curcumin-induced autophagy. Autophagy 3 (6),
635–637.
Sinha, S., Levine, B., 2008. The autophagy effector Beclin 1: a novel BH3-only protein.
Oncogene 27 (Suppl 1), S137–S148.
Sinha, S., Colbert, C.L., Becker, N., Wei, Y., Levine, B., 2008. Molecular basis of the
regulation of Beclin 1-dependent autophagy by the gamma-herpesvirus 68 Bcl-2
homolog M11. Autophagy 4 (8), 989–997.
Sir, D., Chen, W., Choi, J., Wakita, T., Yen, T.S., Ou, J., 2008. Induction of incomplete
autophagic response by hepatitis C virus via the unfolded protein response.
Hepatology 48 (4), 1054–1061.
Snijder, E.J., van der Meer, Y., Zevenhoven-Dobbe, J., Onderwater, J.J., van der Meulen, J.,
Koerten, H.K., Mommaas, A.M., 2006. Ultrastructure and origin of membrane
vesicles associated with the severe acute respiratory syndrome coronavirus
replication complex. J. Virol. 80 (12), 5927–5940.
Song, H., Xia, S.L., Liao, C., Li, Y.L., Wang, Y.F., Li, T.P., Zhao, M.J., 2004. Genes encoding
Pir51, Beclin 1, RbAp48 and aldolase b are up or down-regulated in human primary
hepatocellular carcinoma. WJG 10 (4), 509–513.
Spector, S.A., Zhou, D., 2008. Autophagy: an overlooked mechanism of HIV-1
pathogenesis and neuroAIDS? Autophagy 4 (5), 704–706.
Stertz, S., Reichelt, M., Spiegel, M., Kuri, T., Martínez-Sobrido, L., García-Sastre, A.,
Weber, F., Kochs, G., 2007. The intracellular sites of early replication and budding of
SARS-coronavirus. Virology 361 (2), 304–315.
Suhy, D.A., Giddings, T.H., Kirkegaard, K., 2000. Remodeling the endoplasmic reticulum
by poliovirus infection and by individual viral proteins: an autophagy-like origin
for virus-induced vesicles. J. Virol. 74 (19), 8953–8965.Takahashi, M.N., Jackson, W., Laird, D.T., Culp, T.D., Grose, C., Haynes, J.I., Benetti, L.,
2009. Varicella-zoster virus infection induces autophagy in both cultured cells and
human skin vesicles. Journal of Virology 83 (11), 5466–5476.
Takeuchi, O., Akira, S., 2007. Signaling pathways activated by microorganisms. Curr.
Opin. Cell Biol. 19 (2), 185–191.
Tal, M.C., Sasai, M., Lee, H.K., Yordy, B., Shadel, G.S., Iwasaki, A., 2009. Absence of
autophagy results in reactive oxygen species-dependent ampliﬁcation of RLR
signaling. Proc. Natl. Acad. Sci. U. S. A. 106 (8), 2770–2775.
Tallóczy, Z., Jiang, W., Virgin, H., Leib, D.A., Scheuner, D., Kaufman, R.J., Eskelinen, E.L.,
Levine, B., 2002. Regulation of starvation- and virus-induced autophagy by the
eIF2alpha kinase signaling pathway. Proc. Natl. Acad. Sci. U. S. A. 99 (1), 190–195.
Tallóczy, Z., Virgin, H., Levine, B., 2006. PKR-dependent autophagic degradation of
herpes simplex virus type 1. Autophagy 2 (1), 24–29.
Tang, H., Da, L., Mao, Y., Li, Y., Li, D., Xu, Z., Li, F., Wang, Y., Tiollais, P., Li, T., Zhao, M., 2009.
Hepatitis B virus X protein sensitizes cells to starvation-induced autophagy via up-
regulation of beclin 1 expression. Hepatology 49 (1), 60–71.
Tanida, I., Fukasawa, M., Ueno, T., Kominami, E., Wakita, T., Hanada, K., 2009.
Knockdown of autophagy-related gene decreases the production of infectious
hepatitis C virus particles. Autophagy 5 (7).
Tasdemir, E., Maiuri, M., Galluzzi, L., Vitale, I., Djavaheri-Mergny, M., D'amelio, M., Criollo,
A., Morselli, E., Zhu, C., Harper, F., Nannmark, U., Samara, C., Pinton, P., Vicencio, J.M.,
Carnuccio, R., Moll, U., Madeo, F., Paterlini-Brechot, P., Rizzuto, R., Szabadkai, G.,
Pierron, G., Blomgren, K., Tavernarakis, N., Codogno, P., Cecconi, F., Kroemer, G., 2008.
Regulation of autophagy by cytoplasmic p53. Nat. Cell Biol. 10 (6), 676–687.
Taylor, M., Kirkegaard, K., 2007. Modiﬁcation of cellular autophagy protein LC3 by
poliovirus. J. Virol. 81 (22), 12543–12553.
Taylor, M., Burgon, T.B., Kirkegaard, K., Jackson, W., 2009. Role of microtubules in
extracellular release of poliovirus. J. Virol. 83 (13), 6599–6609.
Uhl, M., Kepp, O., Jusforgues-Saklani, H., Vicencio, J., Kroemer, G., Albert, M.L., 2009.
Autophagy within the antigen donor cell facilitates efﬁcient antigen cross-priming
of virus-speciﬁc CD8+ T cells. Cell Death Differ. 16 (7), 991–1005.
Ulasov, I., Sonabend, A., Nandi, S., Khramtsov, A., Han, Y., Lesniak, M., 2009. Combination
of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant
glioma through autophagic and apoptotic cell death in vivo. Br. J. Cancer 100 (7),
1154–1164.
Virgin, H., Levine, B., 2009. Autophagy genes in immunity. Nat. Immunol. 10 (5), 461–470.
Wang, J., Whiteman, M.W., Lian, H., Wang, G., Singh, A., Huang, D., Denmark, T., 2009. A
non-canonical MEK/ERK signaling pathway regulates autophagy via regulating
Beclin 1. J. Biol. Chem. 284 (32), 21412–21424.
Wei, Y., Pattingre, S., Sinha, S., Bassik, M., Levine, B., 2008a. JNK1-mediated phosphory-
lation of Bcl-2 regulates starvation-induced autophagy. Mol. Cell 30 (6), 678–688.
Wei, Y., Sinha, S., Levine, B., 2008b. Dual role of JNK1-mediated phosphorylation of Bcl-2
in autophagy and apoptosis regulation. Autophagy 4 (7), 949–951.
Wileman, T., 2006. Aggresomes and autophagy generate sites for virus replication.
Science 312 (5775), 875–878.
Wileman, T., 2007. Aggresomes and pericentriolar sites of virus assembly: cellular
defense or viral design? Annu. Rev. Microbiol. 61, 149–167.
Wong, J., Zhang, J., Si, X., Gao, G., Mao, I., McManus, B.M., Luo, H., 2008. Autophagosome
supports coxsackievirus B3 replication in host cells. J. Virol. 82 (18), 9143–9153.
Wullschleger, S., Loewith, R., Hall, M.N., 2006. TOR signaling in growth andmetabolism.
Cell 124 (3), 471–484.
Xie, Z., Klionsky, D., 2007. Autophagosome formation: core machinery and adaptations.
Nat. Cell Biol. 9 (10), 1102–1109.
Xu, Y., Jagannath, C., Liu, X.D., Sharafkhaneh, A., Kolodziejska, K.E., Eissa, N.T., 2007. Toll-
like receptor 4 is a sensor for autophagy associated with innate immunity.
Immunity 27 (1), 135–144.
Yang, Y., Liang, Z., Gu, Z., Qin, Z., 2005. Molecular mechanism and regulation of
autophagy. Acta Pharmacol. Sin. 26 (12), 1421–1434.
Yokoyama, T., Iwado, E., Kondo, Y., Aoki, H., Hayashi, Y., Georgescu,M., Sawaya, R., Hess, K.,
Mills, G., Kawamura, H., Hashimoto, Y., Urata, Y., Fujiwara, T., Kondo, S., 2008.
Autophagy-inducing agents augment the antitumor effect of telerase-selve oncolytic
adenovirus OBP-405 on glioblastoma cells. Gene Ther. 15 (17), 1233–1239.
Yoon, S.Y., Ha, Y.E., Choi, J.E., Ahn, J., Lee, H., Kweon, H.S., Lee, J.Y., Kim, D.H., 2008.
Coxsackievirus B4 uses autophagy for replication after calpain activation in rat
primary neurons. J. Virol. 82 (23), 11976–11978.
Yorimitsu, T., Nair, U., Yang, Z., Klionsky, D.J., 2006. Endoplasmic reticulum stress
triggers autophagy. J. Biol. Chem. 281 (40), 30299–30304.
Yoshimori, T., Noda, T., 2008. Toward unraveling membrane biogenesis in mammalian
autophagy. Curr. Opin. Cell Biol. 20 (4), 401–407.
Yue, Z., Jin, S., Yang, C., Levine, A.J., Heintz, N., 2003. Beclin 1, an autophagy gene
essential for early embryonic development, is a haploinsufﬁcient tumor suppressor.
Proc. Natl. Acad. Sci. U. S. A. 100 (25), 15077–15082.
Zhang, H., Monken, C.E., Zhang, Y., Lenard, J., Mizushima, N., Lattime, E.C., Jin, S., 2006.
Cellular autophagy machinery is not required for vaccinia virus replication and
maturation. Autophagy 2 (2), 91–95.
Zhao, Z., Thackray, L.B., Miller, B.C., Lynn, T.M., Becker, M.M., Ward, E., Mizushima, N.N.,
Denison, M.R., Virgin, H., 2007. Coronavirus replication does not require the
autophagy gene ATG5. Autophagy 3 (6), 581–585.
Zhou, D., Spector, S.A., 2008. Human immunodeﬁciency virus type-1 infection inhibits
autophagy. AIDS 22 (6), 695–699.
Zhou, Z., Jiang, X., Liu, D., Fan, Z., Hu, X., Yan, J., Wang, M., Gao, G.F., 2009. Autophagy is
involved in inﬂuenza A virus replication. Autophagy 5 (3), 321–328.
Zhu, Y., Vergote, D., Pardo, C., Noorbakhsh, F., McArthur, J.C., Hollenberg, M.D., Overall,
C.M., Power, C., 2009. CXCR3 activation by lentivirus infection suppresses neuronal
autophagy: neuroprotective effects of antiretroviral therapy. FASEB Journal 23 (9),
2928–2941.
